Extensive drug resistant Acinetobacter baumannii: a comparative study between non-colistin based combinations

Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii

(2018) Youfa Qin et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex

(2016) Jung-Jr Ye et al.   BMC INFECTIOUS DISEASES

Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumanniiin a critical setting: a matched cohort analysis

(2014) Yu-Chung Chuang et al.   BMC INFECTIOUS DISEASES

In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii

(2014) Xiaomeng Dong et al.   JOURNAL OF ANTIBIOTICS

In vitroactivity of tigecycline in combination with cefoperazone–sulbactam against multidrug-resistantAcinetobacter baumannii

(2014) Bin Liu et al.   JOURNAL OF CHEMOTHERAPY

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis

(2013) Haiqing Chu et al.   Brazilian Journal of Infectious Diseases

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Treatment ofAcinetobacterInfections

(2010) Joel Fishbain et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004–2007)

(2009) Niels Nørskov-Lauritsen et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

(2008) N. Petrosillo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.

(2008) M. S. Oliveira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY